Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation
Open Access
- 31 January 2001
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 75 (1), 38-45
- https://doi.org/10.1016/s0015-0282(00)01638-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). part I. absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteersFertility and Sterility, 1999
- Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). part II. dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteersFertility and Sterility, 1999
- Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacksHuman Reproduction, 1999
- A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study groupHuman Reproduction, 1998
- Future trends in infertility treatment: Challenges aheadFertility and Sterility, 1997
- Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenismJournal of Assisted Reproduction and Genetics, 1993
- The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trialsFertility and Sterility, 1992
- Will GNRH antagonists be worth the wait?Reproductive Medicine Review, 1992
- GnRH Analogues in Ovarian StimulationAnnals of the New York Academy of Sciences, 1991
- Gonadotropin-Releasing Hormone Analog Design. Structure-Function Studies Toward the Development of Agonists and Antagonists: Rationale and PerspectiveEndocrine Reviews, 1986